Esperion Therapeutics, Inc. earnings per share and revenue

ESPR earnings per share for the last quarter are 0.34 USD whereas the estimation was 0.05 USD which accounts for 598.27% surprise. Company revenue for the same period amounts to 137.74 M USD despite the estimated figure of 83.93 M USD. Estimated earnings per share for the next quarter are -0.18 USD, and revenue is expected to reach 46.73 M USD. Also watch annual changes over time to get a bigger picture of ESPR earnings per share and revenue dynamics.